Risk of Breakthrough Symptoms With Long-Acting Injectable Medications

Clinical trial NCT05473741 · COMPLETED

Trial details

NCT number: NCT05473741
Sponsor: Centre for Addiction and Mental Health
Status: COMPLETED
Study type: OBSERVATIONAL

Schizophrenia Schizophrenia Relapse

Start date: 2023-01-11
Primary completion: 2025-10-27
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.